ABSTRACT
INTRODUCTION
The Zika virus (ZIKV) epidemic first affected countries in the Pacific Rim, and has since spread to the Americas and Asia 1, 2 . The association between ZIKV and increased risk of fetal insult, particularly those fetal insults affecting the brain, was not observed until evidence from Brazil indicated this possible link [3] [4] [5] [6] . Since the original report by Oliveira Melo et al. 4 , it has become clear that the increase in number of children born with microcephaly and severe brain lesions 7 has been caused by the virus. Their report and others that followed showed that affected fetuses may exhibit a complex syndrome, with brain calcifications, ventriculomegaly, corpus callosal and infratentorial anomalies and sometimes ocular anomalies, polyhydramnios, arthrogryposis, brainstem anomalies and intrauterine growth restriction [8] [9] [10] [11] [12] [13] [14] . The first locally transmitted cases of ZIKV in French Guiana were diagnosed in December 2015. Since February 2016, all pregnant women in French Guiana have undergone three serology tests for ZIKV during pregnancy and up to delivery, conducted by the National Referral Centre (NRC) for Arboviruses for French departments in the Americas, located at the Pasteur Institute in French Guiana. When the mother is symptomatic, the infection is confirmed by a positive reverse transcription polymerase chain reaction (RT-PCR) test of the blood or urine 15 and/or by detection of anti-ZIKV antibodies. By 6 July 2016, ZIKV infection had been confirmed in 744 pregnant women in French Guiana 16 . These patients underwent monthly sonographic follow-up in a fetal diagnostic unit. Almost the entire population of western French Guiana is managed in a single center, allowing a population-based study to be performed.
The main objective of this prospective cohort study was to determine whether there is a significant difference in the prevalence of central nervous system (CNS) anomalies and signs of fetal infection between ZIKV-infected patients and those found to be ZIKV negative throughout pregnancy. The findings may confirm the hypothesis that ZIKV infection during pregnancy is the cause of the fetal insult. The secondary objective was to describe the prenatal ultrasound findings that are characteristic of congenital ZIKV syndrome.
PATIENTS AND METHODS
This observational prospective cohort study compared ultrasound findings in ZIKV-seropositive and ZIKVseronegative pregnant patients attending the prenatal diagnostic unit of the Centre Hospitalier de l'Ouest Guyanais (CHOG) between 1 January and 15 July 2016. The study protocol was approved by the institutional review board of the CHOG.
All patients with a singleton or dichorionic twin pregnancy referred to the unit for ultrasound evaluation during pregnancy who were willing to participate in the study after being informed about its purpose were asked to sign an informed consent form. Pregnant patients were defined as ZIKV positive either by a positive RT-PCR result (RealStar ® Zika Kit, Altona Diagnostics GmbH, Hamburg, Germany) from blood and/or urine samples or by anti-ZIKV antibody detection using an in-house (NRC) IgM and IgG antibody-capture enzyme-linked immunosorbent assay.
The timing of infection was established based on the appearance of clinical signs and symptoms or, in their absence, by the laboratory test results. Seronegative patients remained as such for the entire pregnancy and after delivery. Additional samples, including placenta, amniotic fluid and fetal samples, were assayed by RT-PCR to search for the virus in the maternofetal compartment.
Data on demographic characteristics, medical parameters and possible risk factors for congenital diseases were obtained at the beginning of the study. Both groups were followed using the same protocol, which included monthly ultrasound examinations from 11-14 weeks' gestation to the end of pregnancy, with standardized fetal biometric measurements and anatomy survey, with special focus on brain anatomy, as recommended by national and international medical societies 17, 18 . All fetal ultrasound examinations were performed by two sonographers using E8 and E10 GE Voluson machines (GE Healthcare Ultrasound, Milwaukee, WI, USA) with transabdominal and transvaginal transducers. Before the study commenced, both investigators performed 50 examinations together to standardize the procedure, with the purpose of minimizing intraobserver variability. A fetus was considered likely to have microcephaly when head circumference (HC) was more than 2 SD below the norm, according to Collège Français d'Echographie Foetale (CFEF) nomograms, and was considered to have severe microcephaly when HC was more than 3 SD below the norm. Abnormal biometry of brain structures was defined using well-established criteria 17, 18 . Sulcation and gyration, the presence of calcifications, periventricular or cortical hyperechogenicity and the presence of non-CNS signs of infection or neurological involvement were also evaluated.
The presence of extensive brain involvement or a single CNS finding accompanied by more than three non-CNS signs of infection was defined as severe disease. Cases were classified as 'confirmed' following confirmation of the presence of ZIKV in the maternofetal compartment without any other suspected etiology from prenatal and postnatal evaluations, and were classified as 'suspected' when the clinical and ultrasound findings were suggestive of congenital ZIKV syndrome but the presence of ZIKV in the maternofetal compartment was not confirmed.
When one of the investigators suspected an anomaly, the ultrasound images were analyzed by the second investigator, and a multidisciplinary consultation was offered for further evaluation or to consider termination of pregnancy, if requested. Amniocentesis was offered when ultrasound findings led to suspicion of congenital ZIKV syndrome. ZIKV serology and RT-PCR analyses were performed for all newborns at delivery using cord blood as well as RT-PCR analysis of urine. A postmortem examination was performed in all cases of termination of pregnancy due to a fetal abnormality. The incidence of intrauterine fetal death (IUFD) from the second trimester of pregnancy was compared between the two groups.
Statistical analysis was performed using XLStat (Addinsoft, Paris, France). Comparisons between groups were performed using chi-square, Yates correction and Fisher's exact tests for expected counts of > 5, 3-5 and < 3, respectively. The t-test was used for quantitative variables and P < 0.05 was considered statistically significant.
RESULTS

Study population
During the study period, 1690 pregnant women underwent laboratory screening for ZIKV infection, of whom 498 (29.5%) were found to be ZIKV positive by RT-PCR and/or serological analysis. A total of 301 (60.4%) of these infected patients were followed at the CHOG prenatal diagnostic unit and represent the ZIKV-positive cohort.
Fifty-two (17.3%) of these patients presented with clinical symptoms of ZIKV infection (fever, pruritus, erythema, conjunctivitis, arthralgia or myalgia) at 6-32 weeks' gestation and 10 (3.3%) had prolonged viremia throughout pregnancy. Over the same study period, 399 women with negative serology for ZIKV throughout their pregnancy agreed to monthly follow-up ultrasound examinations. A flowchart of the recruitment process and pregnancy outcomes is shown in Figure 1 . Baseline characteristics of participants and comorbidities for fetal CNS anomalies are presented in Table 1 .
The rate of vertical transmission of ZIKV in the infected group was 10.9% (95% CI, 5.9-18.1%); 12/110), as determined by positive RT-PCR results from amniotic fluid samples (3/12) and positive RT-PCR or serology results of the neonate at birth (9/98).
Fetal ultrasound findings
Overall, fetal CNS anomalies were more common in the ZIKV-positive group than in the ZIKV-negative group (9.0% vs 4.3%), with a 2.11-fold (95% CI, 1.18-4.13) increase in relative risk (RR) for those infected. Details of the specific anomalies and signs of infective fetopathy related to the presence of ZIKV and the gestational age at infection are presented in Table 2 .
Details of the nine (3.0%) patients with confirmed or suspected congenital ZIKV syndrome are presented in Table 3 . The sonographic CNS features characteristic of confirmed congenital ZIKV syndrome are presented in Figure 2 . In our study, CNS anomalies were diagnosed as early as 4 weeks after maternal infection. It is worth noting that, whereas five (1.66%) of the ZIKV-positive patients presented with fetuses with HC more than 2 SD below the norm, HC was in the range corresponding to severe microcephaly in only one of these fetuses. These patients became infected in the first and second trimesters. In the control group, only one (0.25%) fetus had suspected microcephaly (RR, 6.63 (95% CI, 0.78-57.83)).
Fetal anomalies of the corpus callosum and the presence of any form of hyperechogenicity were associated with maternal ZIKV infection. In contrast, ventriculomegaly, infratentorial anomalies and abnormal gyration were not found to be significantly increased in infected pregnancies when compared with controls, nor were other signs of infective fetopathy, amniotic fluid volume abnormality or being small-for-gestational age (Table 2) . IUFD occurred more often in the infected group than in controls (RR, 3.98 (95% CI, 1.09-15.17)) and was primarily due to maternal infection in the first and second trimesters of pregnancy. 
DISCUSSION
The severe effects of ZIKV infection on the fetal CNS have been demonstrated in case reports 4,5 and case series 8,9,11 of affected fetuses, but not in a large prospective cohort comparing pregnancies with ZIKVpositive and ZIKV-negative mothers. Our study confirms the hypothesis that infection with ZIKV during pregnancy increases the risk of fetal CNS anomalies two-fold. 21 . During the first period of Data are given as mean (range) or n (%). CMV, cytomegalovirus; HIV, human immunodeficiency virus. the Zika crisis in Brazil, all newborns with HC more than 1 SD below the norm were considered as having microcephaly, creating the false impression that as many as 16% of these newborns were microcephalic 22 . Following changes in the definition of microcephaly, and based on complete examination of more than 50% of the cases, the incidence of reported microcephaly declined steadily 23, 24 . In a study of a group of newborns with suspected microcephaly or CNS involvement, it was found that microcephaly was not invariably present in those with CNS involvement, and cases of severe microcephaly were even less frequent 24 . A preliminary report from Colombia found 20 (1.3%) fetuses with HC more than 2 SD below the norm and four (0.3%) with severe microcephaly among 1484 confirmed cases of maternal ZIKV infection during pregnancy 25 . A retrospective report from French Polynesia showed similar results, with a 0.8% rate of fetal malformation and a 0.52% rate of microcephaly 20 . Although the incidence of microcephaly in our study (1.66%) is close to that reported in the Colombian study, this was not significantly increased when compared with the control group (Table 2) , and the overall rate was lower than the expected 2.3% in the general population 26 . Our findings show that fetal microcephaly does not occur in every case of ZIKV infection and, when present, probably represents only 'the tip of the iceberg' 4 .
ZIKV and microcephaly
ZIKV and fetal insult
The secondary objective of our study was to describe the ultrasound findings in patients with congenital ZIKV syndrome. The incidence of corpus callosal anomalies and the presence of hyperechogenic foci were found to be significantly increased in ZIKV-positive patients when compared with ZIKV-negative patients. These findings are common with other fetal infections, and particularly in cases with severe cytomegalovirus brain involvement.
Although present in some of our cases, other findings described for congenital ZIKV syndrome 5,10,11 were not significantly increased in the ZIKV-positive group ( Table 2 ). The significantly increased risk of IUFD in our study population is similar to that reported from Brazil and Colombia.
Time of infection
Our study confirms previous findings regarding the increased risk of ZIKV transmission and fetal involvement during the first and second trimesters of pregnancy. In fact, all of the patients presenting with severe fetal involvement or IUFD were infected during this period of pregnancy. Third-trimester infection resulted in findings that appeared to be clinically non-specific for congenital ZIKV infection, such as a large placenta, amniotic fluid disturbance and intrauterine growth restriction. It is important to remember that, as with other intrauterine TORCH (toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus, herpes) infections, subclinical disease at birth may result in the late appearance of symptoms, particularly concerning hearing, vision and neurodevelopmental deficits. However, Franca et al. described cases with CNS anomalies that were diagnosed only after delivery following maternal ZIKV infection in the third trimester 24 .
Maternal symptoms and prolonged viremia
We found an apparent increased risk of severe or complex fetal involvement when maternal symptomatology was reported; 66.7% of cases with congenital ZIKV syndrome were identified following the appearance of clinical disease in the mother (Table 3) . These results are similar to those from a recent Brazilian study 24 . In our cohort, we identified a twin pregnancy with IUFD in one fetus and a severe CNS disorder in the second fetus that was associated with prolonged maternal viremia (Case 6, Table 3 ). At least one case of congenital ZIKV syndrome has already been linked to prolonged maternal viremia, possibly due to viral replication in the fetus or placenta 7, 27 .
Vertical transmission
The incidence of maternofetal transmission is not well known for ZIKV, but has been studied for other arboviruses. Generally, transmission in early pregnancy occurs rarely but causes severe disease (embryopathies), whereas transmission in late pregnancy occurs more frequently and causes less severe effects [28] [29] [30] .
The 10.9% vertical transmission rate reported in our study represents the average rate for the entire pregnancy. This estimate may vary depending on the trimester during which the mother became infected, as is the case for other maternofetal infections.
Strengths and limitations
To the best of our knowledge, this is the first study to compare a large cohort of ZIKV-positive patients with a similar group of patients known to remain ZIKV seronegative throughout pregnancy. As an average of four ultrasound examinations were performed for each patient using excellent technical equipment following adequate certification by only two investigators, the possible biases were reduced as much as possible.
The most important limitation of the study is that the results are still preliminary, as many patients had not yet delivered. This has probably resulted in the false-negative diagnosis of patients with less severe disease or those who will go on to develop symptoms later in pregnancy. The possible limitations of current laboratory tests for ZIKV may have introduced misclassifications into the study. The sensitivity and negative predictive value of the serological tests are controversial, following cases with contamination of fetal fluids and tissues in mothers with negative RT-PCR and serology 29 . Importantly, some patients with an initial negative serological result can convert to IgG anti-ZIKV-positive serological status following infection by other arboviruses, not necessarily by ZIKV.
Conclusion
ZIKV infection during pregnancy is associated with a significant risk of fetal CNS involvement and IUFD, particularly when the infection occurs during the first and second trimesters. The estimated vertical transmission rate is 10.9%. Contrary to general understanding, the increase in the risk of microcephaly in the exposed group was at the limit of significance. Our results, being preliminary, should be interpreted with caution. Until more information is obtained, it is paramount to evaluate suspected cases by monthly detailed neurosonographic examinations, with particular attention given to the corpus callosum and presence of hyperechogenic foci. We expect that postnatal follow-up of this cohort will provide a better understanding of the early and late effects of prenatal ZIKV infection, and a thorough knowledge of vertical transmission in association with the trimester of infection.
